Results are presented from 500 ps molecular dynamics simulations
on the native dodecamer d(CGCGAATTCGCG)2 and the lesioned dodecamer containing a
cis,syn-thymine cyclobutane dimer at the TT step.
The
computations, performed with AMBER4.1, included explicitly represented
solvent with periodic boundary conditions
applied within the constant temperature and pressure algorithm.
Electrostatic interactions were calculated with the
particle-mesh Ewald method. Distortions to DNA structure produced
by the lesion were found to be localized at the
dimer site and include mainly a substantial kink in the helical axis,
rolled and tilted base pairs, and weakened hydrogen
bonding at the 5‘ base pair of the lesion. A slight change in
orientation around the glycosyl bond for the 5‘ thymine
of the lesion and highly stiffened deoxyribose rings for both thymine
bases were also observed. The global curvature
of DNA is increased by about 10° by dimer incorporation.
Calculations of H(1‘)-H(6)(pyrimidine) and
H(1‘)-H(8)(purine) interproton distances from the performed simulations agree very
well with the pattern of NMR NOE signals
reported in various dimer containing oligonucleotides, where an
interruption of NOE connectivities is found on the
5‘ side of the lesion. Comparison of the pattern of distortions
observed at the dimer site with the crystal structure
of a complex between dimer-containing DNA and repair enzyme
endonuclease V (Cell
1995, 83,
773−782) leads
to the hypothesis that dimer recognition may involve a whole pattern of
small distortion at the lesion site rather than
one particular structural/dynamical feature associated with the
lesion.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.